BCYC

Bicycle Therapeutics
$3.95
+$0.08 (+2.07%)Jul 27, 2026
2.1FairMoatMint rating

MoatMint rates Bicycle Therapeutics (BCYC) 2.1 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.7 out of 10.

Key metrics

The numbers that frame BCYC today
Market cap
$275.75M
P/E (TTM)
-1.3
EV / FCF
1.2
Gross margin
100%
EV / Sales
-4.2
ROIC
-465.3%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.87
52wk High
$9.16

BCYC stock rating

How BCYC scores on quality, value, growth, momentum and financial health
2.1out of 10
Fair overallNeutral business, valuation unclearTop 79% of ~5,000 US stocks
QualityFair3.7/10
GrowthNeutral4.4/10
MomentumPoor1.5/10
ValueNo scoren/a/10
Financial HealthFair2.5/10

Growth

Revenue and earnings trend for BCYC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about BCYC
Is Bicycle Therapeutics a good buy?
No. Bicycle Therapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case.
What is the market capitalization of BCYC?
Bicycle Therapeutics's market capitalization is $275.75M.
What is the P/E ratio for BCYC stock?
Bicycle Therapeutics's current P/E ratio is -1.3.
What is the 52-week high for BCYC stock?
The 52-week high for Bicycle Therapeutics is $9.16. The current close of $3.95 is 56.9% below that high.
What is the 52-week low for BCYC stock?
The 52-week low for Bicycle Therapeutics is $3.87. The current close of $3.95 is 2.1% above that low.
Does BCYC stock pay dividends?
Bicycle Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BCYC?
Bicycle Therapeutics's Debt / Equity ratio is 0.03.